Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 19/20 | 0.58 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16953011 | 0.86 | AR (0.53) | ARPGR | |
| SCHEMBL16952494 | 0.86 | AR (0.54) | ARTRPV4PGR | |
| SCHEMBL16879240 | 0.86 | AR (0.54) | ARPGR | |
| SCHEMBL19478937 | 0.83 | TRPV4 (0.47) | ARTRPV4PGR | |
| SCHEMBL5203682 | 0.83 | KIF11 (0.53) | ARTRPV4PGR | |
| SCHEMBL7569957 | 0.83 | TRPV4 (0.58) | ARTRPV4 | |
| SCHEMBL7604551 | 0.81 | TRPV4 (0.56) | ARTRPV4 | |
| SCHEMBL17654338 | 0.81 | KIF11 (0.51) | ARTRPV4 | |
| SCHEMBL24176787 | 0.79 | TRPV4 (0.44) | ARTRPV4PGR | |
| SCHEMBL5991602 | 0.79 | AR (0.46) | ARPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023148215-A1 | 3,6-BIS(CYANOMETHYLIDENE)CYCLOHEXA-1,4-DIENE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2023-08-10 | — | — | WO | disclosed |
| EP-4223739-A1 | 3,6-BIS(CYANOMETHYLIDENE)CYCLOHEXA-1,4-DIENE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONIC DEVICES | Novaled GmbH (DE) | 2023-08-09 | — | — | EP | disclosed |
| EP-3666772-A1 | DIARYLTHIOHYDANTOIN COMPOUND AS ANDROGEN RECEPTOR ANTAGONIST | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2020-06-17 | — | — | EP | disclosed |
| EP-2767531-A1 | Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same | Ivachtchenko, Alexandre Vasilievich (US) | 2014-08-20 | — | — | EP | disclosed |
| US-8778219-B2 | Ionic liquids for separation of olefin-paraffin mixtures | UT-BATTELLE, LLC (US) | 2014-07-15 | — | — | US | disclosed |
| US-20130338389-A1 | IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES | UT-BATTELLE, LLC (US) | 2013-12-19 | — | — | US | disclosed |
| US-8535560-B2 | Ionic liquids for separation of olefin-paraffin mixtures | UT-BATTELLE, LLC (US) | 2013-09-17 | — | — | US | disclosed |
| US-20110306615-A1 | NOVEL IMIDAZOLIDINE DERIVATIVE AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-12-15 | — | — | US | disclosed |
| WO-2011008664-A2 | IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES | UT-BATTELLE, LLC (US) | 2011-01-20 | — | — | WO | disclosed |
| US-20110015461-A1 | Ionic Liquids for Separation of Olefin-Paraffin Mixtures | UT-BATTELLE, LLC (US) | 2011-01-20 | — | — | US | disclosed |
| WO-2008121602-A1 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-09 | — | — | WO | disclosed |
| EP-1275637-B1 | Process for the preparation of aromatic nitriles | SALTIGO GMBH (DE) | 2007-01-17 | — | — | EP | disclosed |
| US-6784308-B2 | CATALYZING THE NITRIDING REACTION OF HALOGENOAROMATICS OR ARYL PERFLUOROSULFONATES AND ALKALI METAL CYANIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2004-08-31 | — | — | US | disclosed |
| US-20030018209-A1 | Process for the preparation of aromatic nitriles | LANXESS DEUTSCHLAND GMBH (DE) | 2003-01-23 | — | — | US | disclosed |
| EP-1275637-A1 | Process for the preparation of aromatic nitriles | Bayer Aktiengesellschaft (DE) | 2003-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130338389-A1 | IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES | POU2F1, POU2F2, POF1B | AR 2897/4885TRPV4 822/4885PGR 2672/4885 |
| US-20110306615-A1 | NOVEL IMIDAZOLIDINE DERIVATIVE AND USE THEREOF | CBR1, NR0B1, CNKSR1 | AR 546/4885TRPV4 2232/4885PGR 1300/4885 |
| US-20030018209-A1 | Process for the preparation of aromatic nitriles | AHR, PAH, NISCH | AR 1632/4885TRPV4 836/4885PGR 521/4885 |
| US-20110015461-A1 | Ionic Liquids for Separation of Olefin-Paraffin Mixtures | POU2F1, POU2F2, POF1B | AR 2897/4885TRPV4 822/4885PGR 2672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.